CT angiography first things first

Circulation: Cardiovascular Imaging

Volumn 2, Issue 1, 2009, Pages 1-3

  Lauer, Michael S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Angiography; Editorials; Tomography

Indexed keywords

ANGIOCARDIOGRAPHY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; EDITORIAL; HUMAN; PRIORITY JOURNAL; COMPUTER ASSISTED TOMOGRAPHY; EVIDENCE BASED MEDICINE; NOTE; SENSITIVITY AND SPECIFICITY;

CORONARY ANGIOGRAPHY; EVIDENCE-BASED MEDICINE; HUMANS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350075362     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.108.841429     Document Type: Editorial

References (20)

1. Scherman N.. Pirke Avot, 5:9. The Complete Artscroll Siddur. New York: Mesorah Publications; 2003:575.
2. Johns Hopkins, Medicine Press Release: study supports value of advanced CT scans to check for clogged arteries. Available at: http://www. hopkinsmedicine.org/Press-releases/2008/11-26b-08.html. Accessed on November 28, 2008.
3. Stein PD, Yaekoub AY, Matta F, Sostman HD., 64-Slice CT for diagnosis of coronary artery disease: a systematic review. Am J Med. 2008;121:715-725.
4. Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, Paul N, Clouse ME, Shapiro EP, Hoe J, Lardo AC, Bush DE, de Roos A, Cox C, Brinker J, Lima JAC. performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324-2336.
5. Ostrom MP, Gopal A, Ahmadi N, Nasir K, Yang E, Kakadiaris I, Flores F, Mao SS, Budoff MJ., Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol. 2008;52:1335-1343.
6. Chow BJW, Abraham A, Wells GA, Chen L, Ruddy TD, Yeung Y, Govas N, Galbraith PD, Dennie C, Beanlands RS., Diagnostic accuracy and impact of computed tomographic coronary angiography on utilization of invasive coronary angiography. Circulation: Cardiovasc Imaging. 2009;2:16-23.
7. Booth CM, Mackillop WJ., Translating new medical therapies into societal benefit: the role of population-based outcome studies. JAMA. 2008;300:2177-2179.
8. Pell JP, Haw S, Cobbe S, Newby DE, Pell AC, Fischbacher C, McConnachie A, Pringle S, Murdoch D, Dunn F, Oldroyd K, Macintyre P, O'Rourke B, Borland W. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008;359:482-491.
9. Hachamovitch R, Berman DS., New frontiers in risk stratification using stress myocardial perfusion single photon emission computed tomography. Curr Opin Cardiol. 2003;18:494-502.
10. Topol EJ, Nissen SE., Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995;92:2333-2342.
11. Lord SJ, Irwig L, Simes RJ., When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med. 2006;144:850-855.
12. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE., Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909-919.
13. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, Thompson SG, Walker NM., The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002;360:1531-1539.
14. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, Robertson DH, Hille DA, DeLucca PT, DiBattiste PM, Demopoulos LA, Weintraub WS, Braunwald E., Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA. 2001;286:2405-2412.
15. Woods WG, Gao RN, Shuster JJ, Robison LL, Bernstein M, Weitzman S, Bunin G, Levy I, Brossard J, Dougherty G, Tuchman M, Lemieux B., Screening of infants and mortality due to neuroblastoma. N Engl J Med. 2002;346:1041-1046.
16. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349-360.
17. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, Sigmon K, Anderson KM, Lee KL, Willerson JT, EPIC Investigators. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. Lancet. 1994;343:881-886.
18. Bonow RO., Sixth Annual Mario S. Verani, MD Memorial Lecture: cardiovascular imaging-added value or added cost? J Nucl Cardiol. 2008;15:170-177.
19. Berenson A, Abelson R., The evidence gap: weighing the costs of a CT scan's look inside the heart. New York Times. June 29, 2008.
20. Shah BR, Patel MR, Peterson ED, Douglas PS., Defining optimal research study design for cardiovascular imaging using computed tomography angiography as a model. Am J Cardiol. 2008;102:943-948.